Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Scaling Clinical Diagnostic Testing to the Masses (Part 1)

The rising cost of health care has hit Americans differently depending on their economic status. There is no shortage of news stories covering the reality of  those with higher incomes having higher life expectancies than those in lower financial brackets. Healthcare services such as clinical diagnostic testing may be out of reach for those who…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

The rising cost of health care has hit Americans differently depending on their economic status. There is no shortage of news stories covering the reality of those with higher incomes having higher life expectancies than those in lower financial brackets. Healthcare services such as clinical diagnostic testing may be out of reach for those who could really use it. So what are some the things a company can do to make clinical diagnostic testing more accessible for everyone? How can an important medical test be affordable to all?

On this episode of Health & Life Sciences at the Edge, host Michelle Dawn Mooney talks with Intel Head of Business Innovation and Life Science Specialist Blake Harlan and SiPhox Chief Product Officer Mike Dubrovsky about clinical diagnostic testing, the way it is used, and the way its use can be improved.

“Clinical diagnostic testing is actually a major part of the [healthcare] system,” says Dubrovsky. “Seventy percent of all medical decisions require diagnostic tests. However, the way that it’s done now is very reactive, so the whole system is based on first the patient having symptoms and then they’re put through a series of tests to try to resolve the problem.” Harlan and Dubrovsky further mention how it’s easy for those in higher income brackets to get tested more often, as those types of tests cost much more than the ones for reactive patients who are presently experiencing symptoms.

“The way the healthcare system works now is it’s really set up to, for the person, once they get sick, to deal with that” says Dubrovsky. He points out how the system is primarily designed to treat reactive care. “The problem is that there is a massive rise in healthcare costs, accompanied with actually a decrease in life expectancy, at least in America”, where six out of ten Americans have at least one chronic disease. In a country that spends so much on healthcare research, Harlan and Dubrovsky think the country needs to shift its thinking and policies when it comes to the health of its citizens.

Learn more about network operations center solutions by connecting with Blake Harlan and Mike Dubrovsky on LinkedIn or visiting SiPhox or Intel Health and Life Sciences.

Subscribe to this channel on Apple PodcastsSpotify, and Google Podcasts to hear more from the Intel Network and Edge Solutions Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

A Nature study reveals a significant increase in FDA-authorized digital medical devices over the past two decades. However, the FDA's regulatory databases are still unable to specify which of these devices contain software. This gap points to the need for improved database capabilities to better track digital medical devices.

  • 01FDA-authorized digital medical devices have increased significantly over the last 20 years.
  • 02The current FDA regulatory databases lack the capability to identify devices that include software.

Aug 5, 2026

Leading with Purpose: Dr. David Foster on Faith, Healthcare Leadership, and Physician Collaboration

Dr. David Foster discusses the importance of faith in healthcare leadership and the role of physician collaboration. The conversation emphasizes how values-driven leadership can positively impact patient care. The dialogue also explores the significance of integrating personal beliefs in professional settings.

  • 01Values-driven leadership can significantly enhance patient care.
  • 02Integrating personal beliefs in professional settings can benefit healthcare leadership.
  • 03Collaboration among physicians is crucial for effective healthcare leadership.

Aug 4, 2026

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512